Kristina Schwamborn

Vanderbilt University, Klinikum rechts der Isar

Papers

2

Total Citations

71

H-Index

2

About

Kristina Schwamborn is a leading researcher in translational molecular imaging, with a primary focus on the application of mass spectrometry and theranostic approaches in oncology and inflammatory diseases. Her work has been instrumental in advancing matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry (IMS) as a powerful tool for clinical diagnostics. In her highly cited 2012 study (50 citations), she pioneered the use of MALDI MS imaging to identify and visualize protein biomarker candidates directly in synovial tissue, offering a novel method to distinguish between rheumatoid arthritis and osteoarthritis at the molecular level. This work demonstrated the potential of IMS to map protein distributions in complex tissue microenvironments, providing unprecedented spatial insights into disease pathology. Schwamborn has also made significant contributions to prostate cancer management, notably in her 2016 study (21 citations) on PSMA theranostics, where she integrated PET imaging with subsequent radioguided surgery to improve the detection and treatment of recurrent disease. Her research bridges cutting-edge molecular imaging techniques with direct clinical application, earning her recognition as a key innovator in precision medicine and biomarker discovery.

Research Focus

Key Achievements

2
H-Index
2
Papers
71
Total Citations
36
Avg Citations/Paper
🏆 Most Cited Paper
MALDI MS imaging as a powerful tool for investigating synovial tissue
50 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Vanderbilt University, Klinikum rechts der Isar

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 17 days ago